Extreemely Important Medical News



For educational purposes - no comment:

"NDTV Correspondent

Thursday, December 15, 2005 (Washington):

The US National Cancer Institute has launched a three-year study in
collaboration with the National Human Genome Research Institute to
decipher the genetic makeup of cancer.

Called the 'Cancer Genome Atlas Pilot Project', it will set out to
chart a complete list of DNA abnormalities that lead to cancer.

"Finding the causes of cancer at the DNA level is going to have
profound significance in several ways," said Dr Francis S Collins,
Director, US Genome Institute.

"It will enable us to take what we currently call one disease, let's
say lung cancer, and realise it's actually quite a number of diseases.
It will allow us to do better diagnostics to predict who is going to
respond to which kind of therapy," Dr Collins explained.

Genetic changes

The project will develop a framework to identify and characterise
genetic mutations besides other genetic changes associated with cancer.


"Our purpose in this project is to begin to turn that fear of cancer,
actually America's greatest fear, into a future, not only free of fear,
but full of hope," said Andrew von Eschenbach, Director, US Cancer
Institute.

The pilot study begins by looking at various types of cancer that could
help determine the feasibility of a larger-scale project. This
selection process is currently underway.

Cancer includes over 200 different diseases. In all forms of cancer,
DNA changes cause harmful, uncontrolled cellular growth.

If this cancer genome project proves as successful as the Human Genome
Project, it would mean scientists can develop specific therapies to
target different types of cancer."

http://www.ndtv.com/template/template.asp?template=Health&slug=Scientists+launch+cancer+genome+project&id=82479&callid=1

.



Relevant Pages

  • Re: Article: How good is our genome?
    ... >> Our genome has evolved to perpetuate itself through the maintenance of the ... selection would not result in adaptive evolution. ... >> the TP53 gene may offer a paradigmatic example. ... >> latency period in cancer can be prolonged in mice by increasing the number ...
    (sci.bio.evolution)
  • Article: How good is our genome?
    ... Our genome has evolved to perpetuate itself through the maintenance of the ... that we indeed live as disposable somas, slaves of our germline genome, but ... Cancer and its relation to ... the TP53 gene may offer a paradigmatic example. ...
    (sci.bio.evolution)
  • Re: Cell division creationism
    ... >100 years we will need new cancer chemotherapy drugs because cancer ... its DNA into a cancer-supressing region of the genome. ... Prev by Date: ...
    (talk.origins)
  • HGS-ETR1 aka Mapatumumab (previously known as TRAIL-R1 mAb) is a human monoclonal antibody
    ... Glaxo partners with Human Genome on cancer drug; ... behind an experimental anti-cancer drug being tested by Human Genome ... "It could be the next Avastin," said Hanzhong Li, analyst for Suntrust ...
    (sci.med.diseases.cancer)
  • Researchers Seek Genetic Map of Cancer
    ... Researchers Seek Genetic Map of Cancer ... The other half will come from the National Human Genome ... This VOA Special English Health Report was written by Cynthia Kirk. ...
    (sci.med.diseases.cancer)